HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cotrimoxazole prophylactic treatment prevents malaria in children in sub-Saharan Africa: systematic review and meta-analysis.

AbstractOBJECTIVES:
Cotrimoxazole prophylactic treatment (CPT) prevents opportunistic infections in HIV-infected or HIV-exposed children, but estimates of the effectiveness in preventing malaria vary. We reviewed studies that examined the effect of CPT on incidence of malaria in children in sub-Saharan Africa.
METHODS:
We searched PubMed and EMBASE for randomised controlled trials (RCTs) and cohort studies on the effect of CPT on incidence of malaria and mortality in children and extracted data on the prevalence of sulphadoxine-pyrimethamine resistance-conferring point mutations. Incidence rate ratios (IRR) from individual studies were combined using random effects meta-analysis; confounder-adjusted estimates were used for cohort studies. The importance of resistance was examined in meta-regression analyses.
RESULTS:
Three RCTs and four cohort studies with 5039 children (1692 HIV-exposed; 2800 HIV-uninfected; 1486 HIV-infected) were included. Children on CPT were less likely to develop clinical malaria episodes than those without prophylaxis (combined IRR 0.37, 95% confidence interval: 0.21-0.66), but there was substantial between-study heterogeneity (I-squared = 94%, P < 0.001). The protective efficacy of CPT was highest in an RCT from Mali, where the prevalence of antifolate resistant plasmodia was low. In meta-regression analyses, there was some evidence that the efficacy of CPT declined with increasing levels of resistance. Mortality was reduced with CPT in an RCT from Zambia, but not in a cohort study from Côte d'Ivoire.
CONCLUSIONS:
Cotrimoxazole prophylactic treatment reduces incidence of malaria and mortality in children in sub-Saharan Africa, but study designs, settings and results were heterogeneous. CPT appears to be beneficial for HIV-infected and HIV-exposed as well as HIV-uninfected children.
AuthorsNyanyiwe M Mbeye, Feiko O ter Kuile, Mary-Ann Davies, Kamija S Phiri, Matthias Egger, Gilles Wandeler, IeDEA-Southern Africa
JournalTropical medicine & international health : TM & IH (Trop Med Int Health) Vol. 19 Issue 9 Pg. 1057-67 (Sep 2014) ISSN: 1365-3156 [Electronic] England
PMID25039469 (Publication Type: Journal Article, Meta-Analysis, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review, Systematic Review)
Copyright© 2014 John Wiley & Sons Ltd.
Chemical References
  • Antimalarials
  • Drug Combinations
  • fanasil, pyrimethamine drug combination
  • Trimethoprim, Sulfamethoxazole Drug Combination
  • Sulfadoxine
  • Pyrimethamine
Topics
  • Africa South of the Sahara (epidemiology)
  • Antimalarials (therapeutic use)
  • Child
  • Drug Combinations
  • Drug Resistance (genetics)
  • HIV Infections (complications)
  • Humans
  • Malaria (complications, mortality, prevention & control)
  • Mutation
  • Pyrimethamine (therapeutic use)
  • Sulfadoxine (therapeutic use)
  • Trimethoprim, Sulfamethoxazole Drug Combination (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: